GM-CSF/IL-3/IL-5 receptor common β chain (CD131) expression as a biomarker of antigen-stimulated CD8+ T cells
Open Access
- 15 April 2008
- journal article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 6 (1) , 17
- https://doi.org/10.1186/1479-5876-6-17
Abstract
Background: Upon Ag-activation cytotoxic T cells (CTLs) produce IFN-γ GM-CSF and TNF-α, which deliver simultaneously pro-apoptotic and pro-inflammatory signals to the surrounding microenvironment. Whether this secretion affects in an autocrine loop the CTLs themselves is unknown.Methods: Here, we compared the transcriptional profile of Ag-activated, Flu-specific CTL stimulated with the FLU M1:58-66 peptide to that of convivial CTLs expandedin vitroin the same culture. PBMCs from 6 HLA-A*0201 expressing donors were expanded for 7 days in culture following Flu M1:58-66 stimulation in the presence of 300 IU/ml of interleukin-2 and than sorted by high speed sorting to high purity CD8+ expressing T cells gated according to FluM1:58-66 tetrameric human leukocyte antigen complexes expression.Results: Ag-activated CTLs displayed higher levels of IFN-γ, GM-CSF (CSF2) and GM-CSF/IL-3/IL-5 receptor common β- chain (CD131) but lacked completely expression of IFN-γ receptor-II and IFN-stimulated genes (ISGs). This observation suggested that Ag-activated CTLs in preparation for the release of IFN-γ and GM-CSF shield themselves from the potentially apoptotic effects of the former entrusting their survival to GM-SCF.In vitrophenotyping confirmed the selective surface expression of CD131 by Ag-activated CTLs and their increased proliferation upon exogenous administration of GM-CSF.Conclusion: The selective responsiveness of Ag-activated CTLs to GM-CSF may provide an alternative explanation to the usefulness of this chemokine as an adjuvant for T cell aimed vaccines. Moreover, the selective expression of CD131 by Ag-activated CTLs proposes CD131 as a novel biomarker of Ag-dependent CTL activation.Keywords
This publication has 21 references indexed in Scilit:
- Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejectionGenome Biology, 2007
- Signals required for programming effector and memory development by CD8+ T cellsImmunological Reviews, 2006
- Quiescent phenotype of tumor-specific CD8+ T cells following immunizationBlood, 2004
- Molecular Heterogeneity in Acute Renal Allograft Rejection Identified by DNA Microarray ProfilingNew England Journal of Medicine, 2003
- Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivoNature Medicine, 2003
- Lineage relationship and protective immunity of memory CD8 T cell subsetsNature Immunology, 2003
- Molecular and Functional Profiling of Memory CD8 T Cell DifferentiationCell, 2002
- Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administrationGenome Biology, 2002
- Increased Vaccine-Specific T Cell Frequency After Peptide-Based Vaccination Correlates with Increased Susceptibility to In Vitro Stimulation But Does Not Lead to Tumor RegressionThe Journal of Immunology, 1999
- Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas.The Journal of Immunology, 1992